Rössler Julian, Ott Sascha, Li Yufei, Turan Alparslan, Yazar Mehmet, Müller-Wirtz Lukas M, Demirjian Sevag, Shaw Andrew, Ruetzler Kurt
Outcomes Research Consortium, Houston, TX, USA; Institute of Anesthesiology, University Hospital Zurich, Zurich, Switzerland.
Outcomes Research Consortium, Houston, TX, USA; Deutsches Herzzentrum der Charité, Department of Cardiac Anesthesiology and Intensive Care Medicine, Berlin, Germany; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany.
J Clin Anesth. 2025 Mar;102:111745. doi: 10.1016/j.jclinane.2025.111745. Epub 2025 Jan 16.
Chronic-kidney-disease (CKD) is prevalent among adults undergoing noncardiac surgery, with surgery-related factors potentially worsening CKD or triggering acute kidney injury (AKI). We hypothesized that CKD patients experience more kidney function decline within one to two years post-surgery than those without CKD, particularly if they develop AKI.
We conducted a single-center retrospective cohort study, including noncardiac surgery patients with documented creatinine preoperative and between 1 and 2 years after surgery. The primary outcome was long-term course of kidney function, defined as the change in estimated glomerular filtration rate (eGFR) in mL/min/1.73m.
Of 58,175 included cases, 17 % had preoperative CKD. Mean eGFR changed from 90.1 ± 16.7 to 92.0 ± 18.8 in non-CKD patients and from 45.6 ± 11.9 to 55.6 ± 20.1 in patients with CKD, with an estimated difference in means of 8.9 (95 % CI: 8.5, 9.3; P < 0.0001). There was a significant interaction between CKD-dependent eGFR change from baseline to follow-up and postoperative AKI (P = 0.001). For cases with preoperative CKD, eGFR increase from baseline to follow-up was 11.7 ± 18.0 with no AKI, 7.7 ± 17.9 with AKI stage 1, 2.4 ± 15.0 with AKI stage 2, and 7.3 ± 25.8 with AKI stage 3. For non-CKD patients, eGFR increased from baseline by 2.3 ± 13.7 with no AKI but decreased by 5.5 ± 19.0 with AKI stage 1, 7.7 ± 21.8 with AKI stage 2, and 9.3 ± 21.3 with AKI stage 3.
Contrary to expectations, patients with preoperative CKD experienced a significant improvement in eGFR postoperatively. Patients without CKD exhibited minimal change. Postoperative AKI negated the eGFR improvement in CKD patients and exacerbated the decline in non-CKD patients.
慢性肾脏病(CKD)在接受非心脏手术的成年人中普遍存在,手术相关因素可能会使CKD恶化或引发急性肾损伤(AKI)。我们假设,与无CKD的患者相比,CKD患者在术后一到两年内肾功能下降更多,尤其是发生AKI时。
我们进行了一项单中心回顾性队列研究,纳入术前和术后1至2年有肌酐记录的非心脏手术患者。主要结局是肾功能的长期病程,定义为估算肾小球滤过率(eGFR)以mL/min/1.73m为单位的变化。
在纳入的58175例病例中,17%术前患有CKD。非CKD患者的平均eGFR从90.1±16.7变为92.0±18.8,CKD患者从45.6±11.9变为55.6±20.1,平均差异估计为8.9(95%CI:8.5,9.3;P<0.0001)。从基线到随访的CKD依赖性eGFR变化与术后AKI之间存在显著交互作用(P=0.001)。对于术前患有CKD的病例,从基线到随访eGFR的增加在无AKI时为11.7±第十八条0,AKI 1期时为7.7±17.9,AKI 2期时为2.4±15.0,AKI 3期时为7.3±25.8。对于非CKD患者,无AKI时eGFR从基线增加2.3±13.7,AKI 1期时下降5.5±19.0,AKI 2期时增加7.7±21.8,AKI 3期时增加9.3±21.3。
与预期相反,术前患有CKD的患者术后eGFR有显著改善。无CKD的患者变化极小。术后AKI抵消了CKD患者eGFR的改善,并加剧了非CKD患者的下降。